Details for New Drug Application (NDA): 018799
✉ Email this page to a colleague
The generic ingredient in PRALIDOXIME CHLORIDE is pralidoxime chloride. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pralidoxime chloride profile page.
Summary for 018799
Tradename: | PRALIDOXIME CHLORIDE |
Applicant: | Baxter Hlthcare Corp |
Ingredient: | pralidoxime chloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 300MG/ML | ||||
Approval Date: | Dec 13, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 018799
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare Corp | PRALIDOXIME CHLORIDE | pralidoxime chloride | INJECTABLE;INJECTION | 018799-001 | Dec 13, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription